Cambridge Cognition
Neuroscience technology
- 21-100 employees
- Healthcare
- B2B
- SaaS
- MedTech
- Bottisham, UK
Jump to section
Company mission
To improve patient outcomes by providing the technology to better understand, detect and treat conditions affecting brain health.
Our take
Neuroscience is one of the most important frontiers of modern medical research, and Cambridge Cognition sets out to help us learn about the brain more quickly, easily and efficiently than ever before.
It uses cost-effective technology to improve the outcomes of clinical trials by offering large-scale, virtual patient screening. This enables studies to bring the best set of patients to trial. The company also consults on optimal trial design, and can run fully remote clinical trials, revolutionising the way medical research is done in an increasingly remote-first world.
Cambridge Cognition already works with some of the world’s top pharmaceutical companies, including Pfizer, GSK and the NHS. It has undertaken a number of acquisitions that put it in an even better place to lead the market in virtual clinical trials.
Steph
Company Specialist at Welcome to the Jungle
Benefits
- Hybrid work options
- 26 days annual leave per year plus bank holidays
- Generous pension with up to 6.5% company contribution
- Life assurance 2x base salary
- Private Health Insurance - Bupa Insurance, Simply Health Cashback Scheme
- Share options – a % of base salary, with nominal exercise price and vesting over 3 years (subject to board approval)
Funding (last 2 of 4 rounds)
May 2024
$1.6m
GRANT
Feb 2018
$0.2m
GRANT
Total funding: $2.4m
Leadership
Rob Baker
(CEO)Joined the company as Head of Product in 2022, moving through a number of leadership roles before becoming CEO in 2025. Prior to this, they spent 5 years at Amazon, ultimately as a Senior Product Manager, and 8 years at Siemens, ultimately as a Regional Branch Manager.